Cannara Biotech price target raised by C$0.75 at TD Securities

 Cannara Biotech price target raised by C$0.75 at TD Securities

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…

Regulatory Environment and Licensing Risk: The cannabis industry is subject to extensive and evolving regulations at federal, provincial, and municipal levels in Canada. Changes in laws, licensing re…